Investigation on the micelle-sensitized Ce (IV) - Lornoxicam-Rh B chemiluminescence system and its application

Journal of Fluorescence

Volumn 22, Issue 1, 2012, Pages 529-535

  Zhao, Fang ^a   Zhao, Wenhui ^b  

^a Xinjiang Bintuan Key Lab of Chemical Engineering for Green Process   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Ce (IV); Chemiluminescence; Lornoxicam; Rh B; Sodium dodecyl benzene sulfonate

Indexed keywords

ACIDIC SOLUTIONS; CL REACTION; DETECTION LIMITS; EXPERIMENTAL CONDITIONS; HUMAN SERUM; LORNOXICAM; RELATIVE STANDARD DEVIATIONS; REPLICATE MEASUREMENTS; SENSITIVE FLOW; SODIUM DODECYL BENZENE SULFONATE;

BODY FLUIDS; MICELLES; RHODIUM; SODIUM;

CHEMILUMINESCENCE;

CERIUM; DRUG DERIVATIVE; LORNOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; RHODAMINE; RHODAMINE B;

ARTICLE; BLOOD; CHEMISTRY; ENERGY TRANSFER; FLOW INJECTION ANALYSIS; HUMAN; LUMINESCENCE; METHODOLOGY; MICELLE; URINE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CERIUM; ENERGY TRANSFER; FLOW INJECTION ANALYSIS; HUMANS; LUMINESCENT MEASUREMENTS; MICELLES; PIROXICAM; RHODAMINES;

EID: 84857652688     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10895-011-0987-z     Document Type: Article

References (37)

1. Radhofer-Welte S, Rabasseda X (2000) Lornoxicam, a new potent NSAID with an improved tolerability profile. Drugs Today 36:55-76 (Pubitemid 30120655)
2. Balfour JA, Fitton A, Barradell LB (1996) Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs 51:639-657
3. Olkkola KT, Brunetto AV, Mattila MJ (1994) Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Clin Pharmacokinet 26:107-120 (Pubitemid 24064235)
4. Vane JR, Botting RM (1998) Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47:S78-S87 (Pubitemid 28493273)
5. Berg J, Christoph T, Widerna M, Bodenteich A (1997) Isoenzyme-specific cyclooxygenase inhibitors: a whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line Mono Mac6. J Pharmacol Toxicol Meth 37:179-186. doi:10.1016/s1056-8719(97)00016-6 (Pubitemid 27380384)
6. Berg J, Fellier H, Christoph T, Grarup J, Stimmeder D (1999) The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro. Inflamm Res 48:369-379. doi:10.1007/s000110050474 (Pubitemid 29361246)
7. Memiş D, Karamanhoǧlu B, Turan A, Koyuncu O, Pamukçu Z (2004) Effects of lornoxicam on the physiology of severe sepsis. Crit Care 8:R474-R482. doi:10.1186/cc2969
8. Byrav PDS, Medhi B, Prakash A, Patyar S, Wadhwa S (2009) Lornoxicam: a newer NSAID. IJPMR 20:27-31
9. Skjodt NM, Davies NM (1998) Clinical pharmacokinetics of lornoxicam: a short half-life oxicam. Clin Pharmacokinet 34:421-428 (Pubitemid 28271895)
10. Taha EA, Salama NN, Abdel FLS (2006) Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-Chloro-4-nitrobenz-2-oxa-1, 3-diazole (NBD-Cl). Chem Pharma Bull 54:653-658. doi:10.1248/cpb.54.653
11. Taha EA, El-Zanfally ES, Salama NN (2003) Ratio derivative spectrophotometric method for the determination of some oxicams in presence of their alkaline degradation products. Sci Pharm 71:303-320 (Pubitemid 38044442)
12. Nemutlu E, Demircan S, Kir S (2005) Determination of lornoxicam in pharmaceutical preparations by zero and first order derivative UV spectrophotometric methods. Pharmazie 60:421-425 (Pubitemid 40966297)
13. Venumadhav E, Neeha T, Bhargavi P, Nishat A, Swetha A, Rao GD (2010) New spectrophotometric methods for the determination of lornaxicam in pharmaceutical dosage forms. Int J Pharma Bio Sci 1:491-494
14. Singh B, Saini G, Sharma DNN, Roy SD, Gautam N (2011) Estimation of lornoxicam in tablet dosage form by UV spectrophotometric method. IJPSR 2(1):102-106
15. Ghoneim MM, Beltagi AM, Radi A (2002) Square-wave adsorptive stripping voltammetric determination of the anti-inflammatory drug lornoxicam. Anal Sci 18(2): 183-186. doi:10.2116/analsci.18.183
16. Ibrahim C, Nisa K, Sule A (2009) Polarographic determination of lornoxicam in pharmaceutical formulations. CBU J Sci 5:11-18
17. Patel DJ, Patel VP (2010) Simultaneous determination of paracetamol and lornoxicam in tablets by thin layer chromatography combined with densitometry. Int J Chem Tech Res 2:1929-1932
18. Taha EA, Salama NN, Abdel FLS (2004) Stability-indicating chromatographic methods for the determination of some oxicams. J AOAC Int 87:366-373
19. Patil KR, Rane VP, Sangshetti JN, Shinde DB (2009) Stability-indicating LC method for analysis of lornoxicam in the dosage form. Chromatographia 69:1001-1005. doi:10.1365/s10337-009-0982-6
20. Radhofer-Weltea S, Dittrichb P (1998) Determination of the novel non-steroidal anti-inflammatory drug lornoxicam and its main metabolite in plasma and synovial fluid. J Chromatogr B 707:151-159. doi:10.1016/s0378- 4347(97)00597-5 (Pubitemid 28198048)
21. Shah DA, Patel NJ, Baldania SL, Chhalotiya UK, Bhatt KK (2011) Stability indicating LC-method for estimation of paracetamol and lornoxicam in combined dosage form. Sci Pharm 79:113-122. doi:10.3797/scipharm.1012-03
22. Attimarad M (2010) Rapid RP HPLC method for quantitative determination of lornoxicam in tablet. J Basic Clin Pharma 1:115-118
23. Akiko N, Mihoko N, Mitsuhiro W, Kenichiro N (2005) Semimicro column HPLC of three oxicam non-steroidal anti-inflammatory drugs in human blood. Bunseki Kagaku 54:755-760
24. Sahoo M, Syal P, Ingale S, Ingale K, Sindhe S, Sali M, Choudhari VP, Kuchekar BS (2011) Development and validation of a RP-HPLC-PDA method for simultaneous determination of lornoxicam and thiocolchicoside in pharmaceutical dosage form and its application for dissolution study. Int J Res Pharm Sci 2:1-7
25. Suwa T, Urano H, Shinohara Y, Kokatsu J (1993) Simultaneous high performance liquid chromatographic determination of lornoxicam and its 5′-hydroxy metabolite in human plasma using electrochemical detection. J Chromatogr Biomed 617:105-110. doi:10.1016/0378-4347(93)80427-6 (Pubitemid 23221019)
26. Kim YH, Ji HY, Park ES, Chae SW, Lee HS (2007) Liquid chromatography-electrospray lonization tandem mass spectromet-ric determination of lornoxicam in human plasma. Arch Pharm Res 30:905-910. doi:10.1007/BF02978844
27. Zeng YL, Chen XY, Zhang YF, Zhong DF (2004) Determination of lornoxicam in human plasma by LC/MS/MS. Pharmaceutica Sinica 39:132-135
28. Mervartová K, Polášek M, Calatayud JM (2007) Recent applications of flow-injection and sequential-injection analysis techniques to chemiluminescence determination of pharmaceuticals. J Pharmaceut Biomed 45:367-381. doi:10.1016/j.jpba.2007.08.018 (Pubitemid 47588775)
29. Adcock JL, Francis PS, Barnett NW (2007) Acidic potassium permanganate as a chemiluminescence reagent-A review. Anal Chim Acta 601:36-67. doi:10.1016/j.aca.2007.08.027 (Pubitemid 47451316)
30. Bostick DT, Hercules DM (1975) Quantitative determination of blood glucose using enzyme induced chemiluminescence of luminol. Anal Chem 47:447-452. doi:10.1021/ac60353a039
31. Malavolti NL, Pilosof D, Nieman TA (1985) Determination of cholesterol with a microporous membrane chemiluminescence cell with cholesterol oxidase in solution. Anal Chim Acta 170:199-207. doi:10.1016/s0003-2670(00)81743-2
32. Zhao F, Bian L (2010) Cerium (IV)-based chemiluminescence of felodipine sensitized by rhodamine 6 G. Instrum Sci Technol 38:366-375. doi:10.1080/10739149.2010.509141
33. Wolkoff AW, Larose RH (1975) Separation and detection of low concentrations of polythionates by high speed anion exchange liquid chromatography. Anal Chem 47:1003-1008. doi:10.1021/ac60357a009
34. Kamruzzaman M, Alam AM, Ferdous T, Lee SH, Kim YH, Kim SH (2011) Ultrasensitive study of gatifloxacin based on its enhancing effect on the cerium (IV)-sodium hyposulfite chemilu-minescence reaction in a micellar medium. J Fluoresc 21:1539-1545. doi:10.1007/s10895-011-0842-2
35. Kenner CT, Busch KW (1979) Quantitative analysis. Macmillan, New York
36. Job P (1928) Formation and stability of inorganic complexes in solution. Ann Chim 9:113-113
37. 2- - Rh6G-SDBS system and its application to the determination of sulfite. Chinese J Chem 24:65-71. doi:10.1002/cjoc.200690023